Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 15:12:03 UTC |
---|
Update Date | 2022-03-07 02:49:16 UTC |
---|
HMDB ID | HMDB0002685 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Prostaglandin F1a |
---|
Description | Prostaglandin F1a is derived mainly from Prostaglandin E1, and is metabolized to 6-Keto Prostaglandin F1a. Prostaglandin F1a is excreted directly into the urine. Prostaglandin F1a contracts the circular muscle of the gut in opposition to the Prostaglandins of the E series. Prostaglandin F1a is a cytoprotector, protecting mucosal tissue from damage produced by ulcerogenic stimuli.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. |
---|
Structure | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-Oic acid | ChEBI | PGF 1-alpha | ChEBI | Prostaglandin F1 | ChEBI | Prostaglandin F1-alpha | ChEBI | (13E,15S)-9a,11a-9,11,15-Trihydroxyprost-13-en-1-Oate | Generator | (13E,15S)-9a,11a-9,11,15-Trihydroxyprost-13-en-1-Oic acid | Generator | (13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-Oate | Generator | (13E,15S)-9Α,11α-9,11,15-trihydroxyprost-13-en-1-Oate | Generator | (13E,15S)-9Α,11α-9,11,15-trihydroxyprost-13-en-1-Oic acid | Generator | PGF 1-a | Generator | PGF 1-Α | Generator | Prostaglandin F1-a | Generator | Prostaglandin F1-α | Generator | 3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoate | HMDB | 3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoic acid | HMDB | 9a,11a,15(S)-Trihydroxy-13-trans-prostenoate | HMDB | 9a,11a,15(S)-Trihydroxy-13-trans-prostenoic acid | HMDB | Prostaglandin F1alpha | HMDB, MeSH | PGF1 | MeSH, HMDB | Prostaglandin F1, (9alpha,11beta,13E,15S)-isomer | MeSH, HMDB | PGF1alpha | MeSH, HMDB | PGF1 alpha | MeSH, HMDB | Prostaglandin F1, (9alpha,11alpha,13E,15S)-(+-)-isomer | MeSH, HMDB | Prostaglandin F1, (8beta,9alpha,11alpha,13E,15S)-isomer | MeSH, HMDB | Prostaglandin F1, (9alpha,11alpha,13E,15R)-isomer | MeSH, HMDB | PGF1a | Generator, HMDB | PGF1Α | Generator, HMDB |
|
---|
Chemical Formula | C20H36O5 |
---|
Average Molecular Weight | 356.4968 |
---|
Monoisotopic Molecular Weight | 356.256274262 |
---|
IUPAC Name | 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid |
---|
Traditional Name | prostaglandin f1α |
---|
CAS Registry Number | 745-62-0 |
---|
SMILES | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O |
---|
InChI Identifier | InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1 |
---|
InChI Key | DZUXGQBLFALXCR-CDIPTNKSSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Long-chain fatty acid
- Fatty alcohol
- Hydroxy fatty acid
- Cyclopentanol
- Cyclic alcohol
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Alcohol
- Organic oxygen compound
- Carbonyl group
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Prostaglandin F1a,1TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C | 2891.7 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TMS,isomer #2 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O | 2780.4 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TMS,isomer #3 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O | 2773.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C | 2848.1 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C | 2773.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #2 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C | 2773.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #3 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2860.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O | 2755.7 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #5 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C | 2774.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TMS,isomer #6 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C | 2761.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C | 2749.4 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TMS,isomer #2 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2780.8 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TMS,isomer #3 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2767.2 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C | 2751.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,4TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2792.9 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3150.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TBDMS,isomer #2 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O | 2997.7 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TBDMS,isomer #3 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O | 2995.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,1TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C | 3114.4 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3254.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #2 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3257.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #3 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3393.3 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O | 3209.1 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #5 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C | 3240.5 | Semi standard non polar | 33892256 | Prostaglandin F1a,2TBDMS,isomer #6 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C | 3237.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3467.5 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TBDMS,isomer #2 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3511.2 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TBDMS,isomer #3 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3513.7 | Semi standard non polar | 33892256 | Prostaglandin F1a,3TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C | 3458.0 | Semi standard non polar | 33892256 | Prostaglandin F1a,4TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3683.4 | Semi standard non polar | 33892256 |
|
---|
General References | - Beitz J, Forster W: Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity. Biochim Biophys Acta. 1980 Dec 5;620(3):352-5. [PubMed:6786342 ]
- Sutton JG, Bosley C, Rands A: The detection by enzyme linked immunosorbent assay of P30 and 19-OH prostaglandin F1/F2, in the presence of a range of possible contaminants. Sci Justice. 1998 Jul-Sep;38(3):157-64. [PubMed:9800431 ]
- King SJ, Sutton JG, Trewsdale LA: Radioimmunoassay detection limits for 19-OH F1 alpha/F2 alpha prostaglandin in normal, infertile and vasectomized semen stains. Analysis of saliva, sweat and urine for possible non-specific or matrix effects. Forensic Sci Int. 1989 Mar;40(3):221-9. [PubMed:2471677 ]
- O'Neill P, Walton S, Foy PM, Shaw MD: Role of prostaglandins in delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery. 1992 Jan;30(1):17-22. [PubMed:1738450 ]
- Schweer H, Seyberth HW, Kuhl PG, Meese CO: Unusual metabolism of prostacyclin in infants with persistent septic pulmonary hypertension. Eicosanoids. 1990;3(4):237-42. [PubMed:2073401 ]
- Barrow SE, Waddell KA, Ennis M, Dollery CT, Blair IA: Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 alpha in biological fluids. J Chromatogr. 1982 Apr 30;239:71-80. [PubMed:7096507 ]
|
---|